 |
PDBsum entry 4lz1
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor/DNA
|
PDB id
|
|
|
|
4lz1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor/DNA
|
 |
|
Title:
|
 |
X-ray structure of the complex between human thrombin and the tba deletion mutant lacking thymine 12 nucleobase
|
|
Structure:
|
 |
Thrombin light chain. Chain: l. Synonym: coagulation factor ii, activation peptide fragment 1, activation peptide fragment 2, thrombin light chain. Thrombin heavy chain. Chain: h. Synonym: coagulation factor ii, activation peptide fragment 1, activation peptide fragment 2, thrombin heavy chain. Thrombin binding aptamer.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Synthetic: yes. Other_details: deletion mutant of the thrombin binding aptamer (tba)
|
|
Resolution:
|
 |
|
1.65Å
|
R-factor:
|
0.157
|
R-free:
|
0.190
|
|
|
Authors:
|
 |
A.Pica,I.Russo Krauss,A.Merlino,F.Sica
|
|
Key ref:
|
 |
A.Pica
et al.
(2013).
Dissecting the contribution of thrombin exosite I in the recognition of thrombin binding aptamer.
Febs J,
280,
6581-6588.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
31-Jul-13
|
Release date:
|
08-Jan-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains L, H:
E.C.3.4.21.5
- thrombin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Gly; activates fibrinogen to fibrin and releases fibrinopeptide A and B.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Febs J
280:6581-6588
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
Dissecting the contribution of thrombin exosite I in the recognition of thrombin binding aptamer.
|
|
A.Pica,
I.Russo Krauss,
A.Merlino,
S.Nagatoishi,
N.Sugimoto,
F.Sica.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Thrombin plays a pivotal role in the coagulation cascade; therefore, it
represents a primary target in the treatment of several blood diseases. The
15-mer DNA oligonucleotide 5'-GGTTGGTGTGGTTGG-3', known as thrombin binding
aptamer (TBA), is a highly potent inhibitor of the enzyme. TBA folds as an
antiparallel chair-like G-quadruplex structure, with two G-tetrads surrounded by
two TT loops on one side and a TGT loop on the opposite side. Previous
crystallographic studies have shown that TBA binds thrombin exosite I by its TT
loops, T3T4 and T12T13. In order to get a better understanding of the
thrombin-TBA interaction, we have undertaken a crystallographic characterization
of the complexes between thrombin and two TBA mutants, TBAΔT3 and TBAΔT12,
which lack the nucleobase of T3 and T12, respectively. The structural details of
the two complexes show that exosite I is actually split into two regions, which
contribute differently to TBA recognition. These results provide the basis for a
more rational design of new aptamers with improved therapeutic action.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|